150 related articles for article (PubMed ID: 8015734)
1. Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment.
Youngren KD; Moghaddam B; Bunney BS; Roth RH
Neurosci Lett; 1994 Jan; 165(1-2):41-4. PubMed ID: 8015734
[TBL] [Abstract][Full Text] [Related]
2. Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.
Jaskiw GE; Kirkbride B; Newbould E; Young D; Durkalski V; Bongiovanni R
Psychopharmacology (Berl); 2005 Jun; 179(4):713-24. PubMed ID: 15682305
[TBL] [Abstract][Full Text] [Related]
3. Chronic clozapine selectively decreases prefrontal cortex dopamine as shown by simultaneous cortical, accumbens, and striatal microdialysis in freely moving rats.
Hernandez L; Hoebel BG
Pharmacol Biochem Behav; 1995 Nov; 52(3):581-9. PubMed ID: 8545478
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study.
Jaskiw GE; Collins KA; Pehek EA; Yamamoto BK
Neuropsychopharmacology; 2001 Jul; 25(1):149-56. PubMed ID: 11377928
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations.
Yamamoto BK; Cooperman MA
J Neurosci; 1994 Jul; 14(7):4159-66. PubMed ID: 7913120
[TBL] [Abstract][Full Text] [Related]
6. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.
Li XM; Perry KW; Wong DT; Bymaster FP
Psychopharmacology (Berl); 1998 Mar; 136(2):153-61. PubMed ID: 9551772
[TBL] [Abstract][Full Text] [Related]
8. BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.
Volonté M; Monferini E; Cerutti M; Fodritto F; Borsini F
J Neurochem; 1997 Jul; 69(1):182-90. PubMed ID: 9202309
[TBL] [Abstract][Full Text] [Related]
9. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.
Nomikos GG; Iurlo M; Andersson JL; Kimura K; Svensson TH
Psychopharmacology (Berl); 1994 Jun; 115(1-2):147-56. PubMed ID: 7862887
[TBL] [Abstract][Full Text] [Related]
10. The effect of clozapine on extracellular dopamine levels in the shell subregion of the rat nucleus accumbens is reversed following chronic administration: comparison with a selective 5-HT(2C) receptor antagonist.
Shilliam CS; Dawson LA
Neuropsychopharmacology; 2005 Feb; 30(2):372-80. PubMed ID: 15562297
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective dopamine depletion in medial prefrontal cortex on basal and evoked extracellular dopamine in neostriatum.
King D; Finlay JM
Brain Res; 1995 Jul; 685(1-2):117-28. PubMed ID: 7583236
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Ichikawa J; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
[TBL] [Abstract][Full Text] [Related]
13. Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus.
Youngren KD; Inglis FM; Pivirotto PJ; Jedema HP; Bradberry CW; Goldman-Rakic PS; Roth RH; Moghaddam B
Neuropsychopharmacology; 1999 May; 20(5):403-12. PubMed ID: 10192821
[TBL] [Abstract][Full Text] [Related]
14. The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study.
Bourdelais AJ; Deutch AY
Cereb Cortex; 1994; 4(1):69-77. PubMed ID: 8180492
[TBL] [Abstract][Full Text] [Related]
15. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
Kuroki T; Meltzer HY; Ichikawa J
J Pharmacol Exp Ther; 1999 Feb; 288(2):774-81. PubMed ID: 9918588
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
[TBL] [Abstract][Full Text] [Related]
17. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
Ichikawa J; Dai J; Meltzer HY
Brain Res; 2002 Jun; 939(1-2):34-42. PubMed ID: 12020849
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of basal and pentylenetetrazol (PTZ)-stimulated dopamine release in the brain of freely moving rats by PTZ-induced kindling.
Dazzi L; Serra M; Porceddu ML; Sanna A; Chessa MF; Biggio G
Synapse; 1997 Aug; 26(4):351-8. PubMed ID: 9215594
[TBL] [Abstract][Full Text] [Related]
19. Loss of dopamine terminals in the medial prefrontal cortex increased the ratio of DOPAC to DA in tissue of the nucleus accumbens shell: role of stress.
King D; Finlay JM
Brain Res; 1997 Sep; 767(2):192-200. PubMed ID: 9367247
[TBL] [Abstract][Full Text] [Related]
20. Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum.
Cartmell J; Salhoff CR; Perry KW; Monn JA; Schoepp DD
Brain Res; 2000 Dec; 887(2):378-84. PubMed ID: 11134627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]